# Antares Pharma, Inc – FDA Inspection, Jan 16, 2025

Source: https://www.keypedia.com/records/fda_inspections/antares-pharma-inc/a7937fcd-171d-4503-8be5-3396181711b9
Source feed: FDA_Inspections

> FDA inspection 1257757 of Antares Pharma, Inc, January 16, 2025. 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1257757
- Company Name: Antares Pharma, Inc
- Inspection Date: 2025-01-16
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Minneapolis District Office
- Citation Count: 0

## Related Documents

- [FDA Inspection 1073695 - 2018-12-04](https://www.keypedia.com/records/fda_inspections/antares-pharma-inc/cf3dc7da-f90a-4788-bcc7-9ec40e1ebdce)
- [FDA Inspection 963398 - 2016-01-21](https://www.keypedia.com/records/fda_inspections/antares-pharma-inc/80b98457-90a0-4a7e-b804-62a14a623d99)
- FDA Inspection 798055 - 2012-09-06
- FDA Inspection 596396 - 2009-07-14

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/elizabeth-r-bloom/51c7ec4e-97bb-4543-adc3-cf02d335f159)
- [Melissa M. Steiger](https://www.keypedia.com/people/melissa-m-steiger/513a7364-15df-474f-8a8a-b5c4ff1cf59f)

Company: https://www.keypedia.com/companies/antares-pharma-inc/27f8256c-c1d6-4d41-b448-7fcac44937dc

Office: https://www.keypedia.com/offices/minneapolis-district-office/c79fc8dc-f884-48fc-ba80-2947f662511d
